Peer Review History
| Original SubmissionNovember 1, 2022 |
|---|
|
PONE-D-22-30143Retention Strategies in the First Pre-Exposure Prophylaxis (PrEP) Observational Cohort among those on Community Supervision in the South: Lessons Learned During the COVID-19 PandemicPLOS ONE Dear Dr. Uhrig Castonguay, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== In your revision, please address all of the reviewers' comments. ============================== Please submit your revised manuscript by Mar 02 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Douglas S. Krakower, MD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please amend your current ethics statement to address the following concerns: a) Did participants provide their written or verbal informed consent to participate in this study? b) If consent was verbal, please explain i) why written consent was not obtained, ii) how you documented participant consent, and iii) whether the ethics committees/IRB approved this consent procedure. 3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 4. Please expand the acronym “NIH, NIMHD, NIEHS” (as indicated in your financial disclosure) so that it states the name of your funders in full. This information should be included in your cover letter; we will change the online submission form on your behalf. 5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 6. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. 7. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This study addresses an important and practical topic relevant to those working with individuals involved in the criminal legal system, both from a research and clinical perspective. Retention in research studies (and clinical care) is critical to the comprehensive understanding of outcomes in this population. The authors provide a well-organized overview of the toolkit that can be used with staff and clients to maximize retention, and include modifications needed during COVID. With regards to the results, they present a remarkably high retention rate with this participant population, especially during a pandemic. It is a missed opportunity to focus only on research studies, as these retention efforts could be critical to the clinical care continuum for many illnesses that are relevant to this patient population—HIV (treatment and prevention), substance use disorder, mental illness, hypertension, etc.—and would recommend broadening the framing of the article as being relevant to both research and clinical care. However, the title as currently written is misleading and would drop the PrEP component as this really is not mentioned in the paper at all. The biggest weakness of this study is that the delivery of specific retention components is not addressed. If the authors have data on this, that should be presented. If every participant received the complete resource-intensive bundle, this should be indicated and recognized as a limitation. What we learn then is that implementing all of these best practices simultaneously can work, but does not help guide those with limited resources as to how best to invest them. Abstract: It is odd that the abstract does not mention PrEP at all. It is also not mentioned in the introduction and since PrEP is really not the focus of the paper, I would remove it from the title Intro Lines 64-66 Although it is understandable that the authors, as researchers focus on retention in research studies, what about retention in clinical care? What about the relationship between retention in study and retention in care? Tables 1 and 2 Thorough but quite large, may be beneficial to fit each one onto one page Methods Primary outcome is retention at 18 months, did virtual /phone visits count for this outcome? All participants were on community supervision, was there any interaction with the study team and probation/parole officers? Results It would be nice to know which retention methods were deployed and how often. Presumably the staff retention training and methods occurred for all staff, but did all participants receive all the retention strategies? As these are labor-intensive endeavors, it would be helpful to know what was truly required to achieve this level of retention. This could help guide future efforts, whether they be in research or for the purposes of providing healthcare or other post-incarceration services, in order to estimate what level of resources are needed to provide these services. Also, some individuals may need less, some may need more engagement to be retained and it would be useful to understand this spectrum. This is reminiscent of a “bundled” approach to quality improvement where it is difficult to tease out what was most effective. Did everyone start out with the same level of retention strategies deployed and then adapted based on need or was is consistent throughout regardless of engagement? The penultimate paragraph of the discussion (is this a limitations paragraph?) addresses this to some degree but would be helpful to describe in methods and/or results how these strategies were deployed to the extent that this was measured. Discussion Would benefit from having an actual limitations paragraph. If the authors are not able to measure which retention strategies were deployed when or some type of “dose” of retention intervention, then this needs to be explicitly stated as a limitation. Also, it may have been helpful to hear from participants what they felt contributed most to retention (either through a survey or qualitative interviews), as this too could help guide future efforts. Reviewer #2: This is an important contribution to a growing body of work that highlights the value of including people with criminal-legal (CL) involvement in research, and strategies to keep participants engaged in the midst of a global pandemic. This is particularly important for populations with overlapping disparities, such as those with CL involvement. I strongly recommend publication, however I have a few suggestions for revisions below: 1) Introduction (Line 72): You discuss retention strategies for criminal-legal (CL) involved individuals, however I wonder if you can include some reasons for loss to follow-up as well (for example, historical mistrust of researchers). Additionally, a brief discussion of trends in retention for different sociodemographic/geographic groups (or lack thereof) would be helpful as this is a component of your analysis. 2) Line 147: What informed your decision to use these specific retention strategies? Including the citation from Table 1 would be helpful here that provides some context and reasoning. 3) Line 151: Generally, across what time period were changes to your retention strategies implemented during the COVID-19 pandemic? As written, the reader is left to infer it was around the time of March 2020. Including a timeline provides more support for your claim that these strategies contributed to a high retention rate. 4) Tables 1 and 2: Different verb tenses and writing styles are used throughout the table in an inconsistent manner. I recommend streamlining them to reflect an objective description of the strategies throughout. I also recommend removing any strategies that were not used in this study from the table instead of denoting them as "Strategy not used in this research study". Strategies that were not used can be disclosed in the manuscript text, however I don't think it is necessary. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Ank Nijhawan Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Retention Strategies among those on Community Supervision in the South: Lessons Learned During the COVID-19 Pandemic PONE-D-22-30143R1 Dear Dr. Uhrig Castonguay, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Douglas S. Krakower, MD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-22-30143R1 Retention Strategies among those on Community Supervision in the South: Lessons Learned During the COVID-19 Pandemic Dear Dr. Uhrig Castonguay: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Douglas S. Krakower Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .